Navigation Links
Bruce Palsulich Joins Relsys International as Chief Innovation & Strategy Officer

IRVINE, Calif., June 23 /PRNewswire/ -- Relsys International, the leading provider of drug safety, pharmacovigilance and risk management solutions for the pharmaceutical industry, announces that Mr. Bruce Palsulich has joined the company as Chief Innovation & Strategy Officer, reporting directly to the CEO. In this role, he will oversee Relsys' future product development and direction, and drive corporate strategic initiatives.

Mr. Palsulich is one of Relsys' original employees, having been with the company since inception. He was formerly Vice President of Product Development at Relsys, departing in 2004 to pursue personal entrepreneurial initiatives. At the time, he was responsible for customer requirements, product direction and business development. Mr. Palsulich is also the original developer of the Argus Safety(TM) suite. He brings with him extensive knowledge and understanding of the pharmaceutical industry, particularly in risk management.

Mr. Dave Bajaj, President & CEO of Relsys, commented, "We welcome Bruce back to the Relsys organization. His return has been very well received by clients who have worked with him in the past. His broad, in-depth understanding of and exposure to global pharmacovigilance business practices will provide the backbone of our future product direction." Mr. Palsulich added, "Relsys has demonstrated unparalleled growth, rapidly gaining the largest user base of any drug safety system in the world. I look forward to working closely with this large client pool to continue to expand Relsys' risk management leadership."

About Relsys International

Relsys International provides the industry-leading Argus suite, a complete systems solution for drug safety, pharmacovigilance and risk management that helps pharmaceutical, biotech and medical device companies improve drug safety and ensure ongoing compliance with global regulations. The company, founded in 1987, works in partnership with its customers to develop and deliver innovative solutions to long-term business needs, and to provide critical components to support its clients' corporate risk management strategies. Argus Safety(TM), the company's flagship product, is the world's best selling drug safety and adverse event reporting software, and is used by more of the leading pharmaceutical companies than any other solution. Relsys is a privately held company, headquartered in Irvine, California. For more information, visit, or call +1 949-453-1715.

SOURCE Relsys International
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Statement by Bruce Bodaken, Chairman & CEO, Blue Shield of California
2. White House awards Weill Cornells Bruce McCandliss highest honor for early career scientists
3. Dr. Lewis Drusin receives American College of Physicians James D. Bruce Memorial Award
4. Statement by Bruce Bodaken on Senate Health Committee Action
5. Allos Therapeutics Appoints Bruce K. Bennett as Vice President, Manufacturing
6. A product for the detection and characterization of brucellosis launched at University of Navarra
7. Richard Greco Joins Mediware Board
8. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
9. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
10. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
11. Nick Childs Joins Grey New York as Director of Content Development
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... , ... People across the U.S. are sharpening their pencils and honing their ... in which patients and their families pay tribute to a genetic counselor by nominating ... of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
(Date:6/24/2016)... June 24, 2016 According to ... Type (Standard Pen Needles, Safety Pen Needles), Needle Length ... Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends ... report studies the market for the forecast period of ... USD 2.81 Billion by 2021 from USD 1.65 Billion ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: